Literature DB >> 26071636

Nitric oxide inhibitory activity and antioxidant evaluations of 2-benzoyl-6-benzylidenecyclohexanone analogs, a novel series of curcuminoid and diarylpentanoid derivatives.

Sze Wei Leong1, Siti Munirah Mohd Faudzi2, Faridah Abas3, Mohd Fadhlizil Fasihi Mohd Aluwi4, Kamal Rullah4, Kok Wai Lam4, Mohd Nazri Abdul Bahari5, Syahida Ahmad5, Chau Ling Tham6, Khozirah Shaari2, Nordin H Lajis7.   

Abstract

A series of twenty-four 2-benzoyl-6-benzylidenecyclohexanone analogs were synthesized and evaluated for their nitric oxide inhibition and antioxidant activity. Six compounds (3, 8, 10, 17, 18 and 19) were found to exhibit significant NO inhibitory activity in LPS/IFN-induced RAW 264.7 macrophages, of which compound 10 demonstrated the highest activity with the IC50 value of 4.2 ± 0.2 μM. Furthermore, two compounds (10 and 17) displayed antioxidant activity upon both the DPPH scavenging and FRAP analyses. However, none of the 2-benzoyl-6-benzylidenecyclohexanone analogs significantly scavenged NO radical. Structure-activity comparison suggested that 3,4-dihydroxylphenyl ring is crucial for bioactivities of the 2-benzoyl-6-benzylidenecyclohexanone analogs. The results from this study and the reports from previous studies indicated that compound 10 could be a candidate for further investigation on its potential as a new anti-inflammatory agent.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  2-Benzoyl-6-benzylidenecyclohexanone; Anti-inflammatory; Antioxidant; RAW 264.7; Stability

Mesh:

Substances:

Year:  2015        PMID: 26071636     DOI: 10.1016/j.bmcl.2015.05.056

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

1.  Curcumin-Synthetic Analogs Library Screening by Docking and Quantitative Structure-Activity Relationship Studies for AXL Tyrosine Kinase Inhibition in Cancers.

Authors:  Fatima Ghrifi; Loubna Allam; Lakhlili Wiame; Azeddine Ibrahimi
Journal:  J Comput Biol       Date:  2019-06-24       Impact factor: 1.479

Review 2.  Immunosuppressive Effects of Natural α,β-Unsaturated Carbonyl-Based Compounds, and Their Analogs and Derivatives, on Immune Cells: A Review.

Authors:  Laiba Arshad; Ibrahim Jantan; Syed Nasir Abbas Bukhari; Md Areeful Haque
Journal:  Front Pharmacol       Date:  2017-01-30       Impact factor: 5.810

3.  Antinociceptive Effect of 3-(2,3-Dimethoxyphenyl)-1-(5-methylfuran-2-yl)prop-2-en-1-one in Mice Models of Induced Nociception.

Authors:  Nur Izzati Ismail; Lee Ming-Tatt; Nordin Lajis; Muhammad Nadeem Akhtar; Ahmad Akira; Enoch Kumar Perimal; Daud Ahmad Israf; Mohd Roslan Sulaiman
Journal:  Molecules       Date:  2016-08-22       Impact factor: 4.411

4.  Antinociceptive activities of a novel diarylpentanoid analogue, 2-benzoyl-6-(3-bromo-4-hydroxybenzylidene)cyclohexen-1-ol, and its possible mechanisms of action in mice.

Authors:  Hui Ming Ong; Ahmad Farhan Ahmad Azmi; Sze Wei Leong; Faridah Abas; Enoch Kumar Perimal; Ahmad Akira Omar Farouk; Daud Ahmad Israf; Mohd Roslan Sulaiman
Journal:  Sci Rep       Date:  2021-12-16       Impact factor: 4.996

Review 5.  Bioactive Diarylpentanoids: Insights into the Biological Effects beyond Antitumor Activity and Structure-Activity Relationships.

Authors:  Joana Moreira; Lucilia Saraiva; Madalena M Pinto; Honorina Cidade
Journal:  Molecules       Date:  2022-09-26       Impact factor: 4.927

6.  In-Vitro and In-Silico Evaluations of Heterocyclic-Containing Diarylpentanoids as Bcl-2 Inhibitors Against LoVo Colorectal Cancer Cells.

Authors:  Sze Wei Leong; Suet Lin Chia; Faridah Abas; Khatijah Yusoff
Journal:  Molecules       Date:  2020-08-26       Impact factor: 4.411

7.  The Involvement of l-Arginine-Nitric Oxide-cGMP-ATP-Sensitive K+ Channel Pathway in Antinociception of BBHC, a Novel Diarylpentanoid Analogue, in Mice Model.

Authors:  Hui Ming Ong; Ahmad Farhan Ahmad Azmi; Sze Wei Leong; Faridah Abas; Enoch Kumar Perimal; Ahmad Akira Omar Farouk; Daud Ahmad Israf; Mohd Roslan Sulaiman
Journal:  Molecules       Date:  2021-12-08       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.